{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013122","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.230785+00:00","generated_at":"2026-05-20T04:10:34.264469+00:00","sec_items":["1.01","3.02","3.03","5.02","5.03","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"INVO restructures NTI holdings with $4.8M note and preferred stock amendments","bullets":["Exchanged 801,196 NTI shares (19.9% stake) for 6,300 NTI Series A Preferred shares, $1,000 stated value each.","NTI issued INVO a $4.8M secured convertible promissory note at 7%, due Nov 2026, convertible upon Qualified IPO or sale.","Exchanged Series C-1 Preferred held by GreenBlock and FNL for Series C-2 Preferred; amended certificates to add redemption rights and reduce conversion price to $1.61.","Amended and Restated Debenture with FNL: $4.8M principal, maturity extended to Feb 2026, plus right to buy up to $10M additional Series C-2 Preferred.","Decathlon and FNL released security interests in NTI assets to facilitate the transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013122","json":"https://secwatch.observer/filing/0001641172-25-013122.json","markdown":"https://secwatch.observer/filing/0001641172-25-013122.md","text":"https://secwatch.observer/filing/0001641172-25-013122.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000164117225013122/0001641172-25-013122-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000164117225013122/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:10:34.264469+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a32a55b5fb","claim":"Dr. Daniel Teper resigned as President at INVO Fertility, Inc..","evidence_excerpt":"On May 28, 2025, Dr. Daniel Teper resigned as President of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000164117225013122/0001641172-25-013122-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}